ALIYA PASIK: Open Payments
NPI 1578992632 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 20 payments from 11 companies in 2025. Trend: 2023 $7,030 · 2024 $881 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 3 | $262 |
| Novo Nordisk Inc | 2 | $249 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| Alkermes, Inc. | 4 | $107 |
| Teva Pharmaceuticals USA, Inc. | 1 | $81 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Noven Therapeutics, LLC | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| ABBVIE INC. | 1 | $15 |
Products named: Dyanavel XR, Ozempic, ABILIFY MAINTENA, AUSTEDO XR, Jornay PM, VIVITROL, FANAPT, ARISTADA.
Industry payments across MI — which companies pay providers there.
